Last reviewed · How we verify

NCT06268171: EchoSS-TP

Ultrasound Assessment of Rectus Femoris Cross-sectionnal Area Following Lung Transplantation

Completed Last updated 12 September 2025
What this trial tests

trial testing ultrasound measurement of the cross-sectional area of the rectus femoris in Lung Transplant in 42 participants. Completed in 27 May 2025.

Timeline
27 March 2024
Primary endpoint
4 April 2025
27 May 2025

Quick facts

Lead sponsorHopital Foch
StatusCompleted
Study typeOBSERVATIONAL
Enrollment42
Start date27 March 2024
Primary completion4 April 2025
Estimated completion27 May 2025
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Hopital Foch — full company profile →

Who can join

18 and older, any sex, with Lung Transplant or Physiotherapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In France, the profile of patients receiving lung transplants has changed in recent years, mainly due to the advent of treatment for cystic fibrosis. This progress has led to an evolution in the patient profile, with an increase in cases of pulmonary fibrosis or COPD, and an increase in the average age of patients. In these older patients, sarcopenia, a condition characterized by loss of muscle mass, is a major concern, as it exacerbates morbidity and mortality. After transplantation, patients are at risk of developing neuromyopathy due to their hospitalization in intensive care. There is currently no effective preventive treatment for this condition, underlining the need for early rehabilitation strategies. The combination of sarcopenia and neuromyopathy diminishes their functional capabilities on discharge from the ICU. Muscle ultrasound, a simple, non-invasive technique, is already used to assess muscle function in intensive care patients. This study aims to evaluate the use of ultrasound to measure muscle loss in lung transplant patients, in particular by examining the rectus femoris muscle. Objectives include observing variations in the surface area of the rectus femoris muscle before and after transplantation, identifying factors influencing this variation, and exploring its relationship with post-transplant morbidity. In summary, this study seeks to better understand muscle loss in lung transplant patients using ultrasound, in order to identify risk factors and guide the development of post-transplant rehabilitation strategies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Lung Transplant

Currently open trials in the same condition.

Other Hopital Foch trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06268171.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing